Lepu Biopharma and AstraZeneca Announce Positive Phase III Results for CMG901 (AZD0901) in Advanced Gastric Cancer Therapy 12
Lepu Biopharma Announces Positive Top-Line Results from CMG9...
Sign in to continue:
Lepu Biopharma Announces Positive Top-Line Results from CMG9...
Keymed Biosciences Announces Positive Phase III Results for ...
Baidu, Inc. Announces Extraordinary General Meeting and Majo...
Transcenta Holding Limited - Investor Update on Measures and...
Antengene Corporation Limited Announces Positive Profit Aler...
Zhongji InnoLight Co., Ltd. Announces Offer Price and Listin...
Foxconn (Far East) Limited to Acquire Major Stake in Maxnerv...
ETHK Labs Inc. Announces Results of Extraordinary General Me...
MOG Digitech Holdings Limited - Rights Issue Detailed Report...
MOG Digitech Holdings Rights Issue: In-Depth Analysis for In...